Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study

Mette S. van Ramshorst, Erik van Werkhoven, Ingrid A.M. Mandjes, Margaret Schot, Jelle Wesseling, Marie Jeanne T.F.D. Vrancken Peeters, Jetske M. Meerum Terwogt, Monique M E M Bos, Hendrika M Oosterkamp, Sjoerd Rodenhuis, Sabine C. Linn, Gabe S Sonke

Research output: Contribution to journal › Article › Academic › peer-review

Fingerprint

Dive into the research topics of 'Trastuzumab in combination with weekly paclitaxel and carboplatin as neo-adjuvant treatment for HER2-positive breast cancer: The TRAIN-study'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science